FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018328995> ?p ?o ?g. }

• W2018328995 endingPage "8807" @default.
• W2018328995 startingPage "8796" @default.
• W2018328995 abstract "Abstract Triantennary N-acetyl galactosamine (GalNAc, GN3), a high-affinity ligand for the hepatocyte-specific asialoglycoprotein receptor (ASGPR), enhances the potency of second-generation gapmer antisense oligonucleotides (ASOs) 6–10-fold in mouse liver. When combined with next-generation ASO designs comprised of short S-cEt (S-2′-O-Et-2′,4′-bridged nucleic acid) gapmer ASOs, ∼60-fold enhancement in potency relative to the parent MOE (2′-O-methoxyethyl RNA) ASO was observed. GN3-conjugated ASOs showed high affinity for mouse ASGPR, which results in enhanced ASO delivery to hepatocytes versus non-parenchymal cells. After internalization into cells, the GN3-ASO conjugate is metabolized to liberate the parent ASO in the liver. No metabolism of the GN3-ASO conjugate was detected in plasma suggesting that GN3 acts as a hepatocyte targeting prodrug that is detached from the ASO by metabolism after internalization into the liver. GalNAc conjugation also enhanced potency and duration of the effect of two ASOs targeting human apolipoprotein C-III and human transthyretin (TTR) in transgenic mice. The unconjugated ASOs are currently in late stage clinical trials for the treatment of familial chylomicronemia and TTR-mediated polyneuropathy. The ability to translate these observations in humans offers the potential to improve therapeutic index, reduce cost of therapy and support a monthly dosing schedule for therapeutic suppression of gene expression in the liver using ASOs." @default.
• W2018328995 created "2016-06-24" @default.
• W2018328995 creator A5009098620 @default.
• W2018328995 creator A5009460254 @default.
• W2018328995 creator A5009867268 @default.
• W2018328995 creator A5011354281 @default.
• W2018328995 creator A5023979875 @default.
• W2018328995 creator A5027687727 @default.
• W2018328995 creator A5031607867 @default.
• W2018328995 creator A5037719221 @default.
• W2018328995 creator A5043961518 @default.
• W2018328995 creator A5044334898 @default.
• W2018328995 creator A5049429301 @default.
• W2018328995 creator A5072979146 @default.
• W2018328995 creator A5077142645 @default.
• W2018328995 creator A5077618800 @default.
• W2018328995 creator A5079060420 @default.
• W2018328995 creator A5079420959 @default.
• W2018328995 creator A5084516005 @default.
• W2018328995 creator A5086530950 @default.
• W2018328995 creator A5090099741 @default.
• W2018328995 creator A5090950544 @default.
• W2018328995 date "2014-07-03" @default.
• W2018328995 modified "2023-10-11" @default.
• W2018328995 title "Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary <i>N</i>-acetyl galactosamine improves potency 10-fold in mice" @default.
• W2018328995 cites W1658581991 @default.
• W2018328995 cites W1738068946 @default.
• W2018328995 cites W1839631757 @default.
• W2018328995 cites W1891781408 @default.
• W2018328995 cites W189780340 @default.
• W2018328995 cites W1964514885 @default.
• W2018328995 cites W1967660067 @default.
• W2018328995 cites W1978266519 @default.
• W2018328995 cites W1985013843 @default.
• W2018328995 cites W1986353574 @default.
• W2018328995 cites W1987196669 @default.
• W2018328995 cites W2008988293 @default.
• W2018328995 cites W2020121619 @default.
• W2018328995 cites W2023523753 @default.
• W2018328995 cites W2024362853 @default.
• W2018328995 cites W2026934511 @default.
• W2018328995 cites W2032596014 @default.
• W2018328995 cites W2040494128 @default.
• W2018328995 cites W2044204671 @default.
• W2018328995 cites W2054032118 @default.
• W2018328995 cites W2064808830 @default.
• W2018328995 cites W2067132479 @default.
• W2018328995 cites W2069146205 @default.
• W2018328995 cites W2077282696 @default.
• W2018328995 cites W2089019006 @default.
• W2018328995 cites W2091117151 @default.
• W2018328995 cites W2092413043 @default.
• W2018328995 cites W2101521513 @default.
• W2018328995 cites W2104341089 @default.
• W2018328995 cites W2112829828 @default.
• W2018328995 cites W2115570439 @default.
• W2018328995 cites W2115656635 @default.
• W2018328995 cites W2130886644 @default.
• W2018328995 cites W2133380348 @default.
• W2018328995 cites W2143461406 @default.
• W2018328995 cites W2149938812 @default.
• W2018328995 cites W2158442258 @default.
• W2018328995 cites W2170210469 @default.
• W2018328995 cites W4238501135 @default.
• W2018328995 doi "https://doi.org/10.1093/nar/gku531" @default.
• W2018328995 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4117763" @default.
• W2018328995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24992960" @default.
• W2018328995 hasPublicationYear "2014" @default.
• W2018328995 type Work @default.
• W2018328995 sameAs 2018328995 @default.
• W2018328995 citedByCount "422" @default.
• W2018328995 countsByYear W20183289952014 @default.
• W2018328995 countsByYear W20183289952015 @default.
• W2018328995 countsByYear W20183289952016 @default.
• W2018328995 countsByYear W20183289952017 @default.
• W2018328995 countsByYear W20183289952018 @default.
• W2018328995 countsByYear W20183289952019 @default.
• W2018328995 countsByYear W20183289952020 @default.
• W2018328995 countsByYear W20183289952021 @default.
• W2018328995 countsByYear W20183289952022 @default.
• W2018328995 countsByYear W20183289952023 @default.
• W2018328995 crossrefType "journal-article" @default.
• W2018328995 hasAuthorship W2018328995A5009098620 @default.
• W2018328995 hasAuthorship W2018328995A5009460254 @default.
• W2018328995 hasAuthorship W2018328995A5009867268 @default.
• W2018328995 hasAuthorship W2018328995A5011354281 @default.
• W2018328995 hasAuthorship W2018328995A5023979875 @default.
• W2018328995 hasAuthorship W2018328995A5027687727 @default.
• W2018328995 hasAuthorship W2018328995A5031607867 @default.
• W2018328995 hasAuthorship W2018328995A5037719221 @default.
• W2018328995 hasAuthorship W2018328995A5043961518 @default.
• W2018328995 hasAuthorship W2018328995A5044334898 @default.
• W2018328995 hasAuthorship W2018328995A5049429301 @default.
• W2018328995 hasAuthorship W2018328995A5072979146 @default.
• W2018328995 hasAuthorship W2018328995A5077142645 @default.
• W2018328995 hasAuthorship W2018328995A5077618800 @default.
• W2018328995 hasAuthorship W2018328995A5079060420 @default.
• W2018328995 hasAuthorship W2018328995A5079420959 @default.

• next